...
dsgn-img

Design Therapeutics Inc, Common Stock

DSGN

NSQ

$6.335

+$0.08

(1.28%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$353.88M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
15.51K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.83
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$2.25 L
$7.77 H
$6.335

About Design Therapeutics Inc, Common Stock

Design Therapeutics, Inc. a biopharmaceutical company, researches, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States. The company utilizes its GeneTAC platform to design and develop therapeutic candidates for inherited diseases caused by nucleotide repeat expansion. Its lead product candidates for potentially disease-modifying treatment comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ systems dependent on mitochondrial function that brings to neurological, cardiac, and metabolic dysfunction; Myotonic Dystrophy Type-1, a dominantly-inherited, monogenic progressive neuromuscular disease affecting skeletal muscle, heart, brain, and other organs; Fuchs Endothelial Corneal Dystrophy, a genetic eye disease characterized by bilateral degeneration of corneal endothelial cells and progressive loss of vision; and Huntington's Disease, a dominantly inherited, monogenic neurodegenerative disease characterized by movement, cognitive, and psychiatric disorders. Design Therapeutics, Inc. was incorporated in 2017 and is headquartered in Carlsbad, California. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameDSGNSectorS&P500
1-Week Return-5.59%-3.39%0.2%
1-Month Return8.51%-1.92%2.72%
3-Month Return8.32%-10.54%7.31%
6-Month Return63.61%-4.47%10.44%
1-Year Return139.46%4.06%27.53%
3-Year Return-61.8%0.94%30.88%
5-Year Return-84.94%36.67%89.21%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue834.00K226.00---[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":0.03,"profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue1.65K5.00K129.00K466.00K537.00K[{"date":"2019-12-31","value":0.31,"profit":true},{"date":"2020-12-31","value":0.93,"profit":true},{"date":"2021-12-31","value":24.02,"profit":true},{"date":"2022-12-31","value":86.78,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit(820.00)(4.77K)(129.00K)(466.00K)(537.00K)[{"date":"2019-12-31","value":-82000,"profit":false},{"date":"2020-12-31","value":-477400,"profit":false},{"date":"2021-12-31","value":-12900000,"profit":false},{"date":"2022-12-31","value":-46600000,"profit":false},{"date":"2023-12-31","value":-53700000,"profit":false}]
Gross Margin(0.10%)(2112.39%)(Infinity%)(Infinity%)(Infinity%)[{"date":"2019-12-31","value":-0.1,"profit":false},{"date":"2020-12-31","value":-2112.39,"profit":false},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]
Operating Expenses1.91M8.33M35.83M67.59M78.19M[{"date":"2019-12-31","value":2.44,"profit":true},{"date":"2020-12-31","value":10.65,"profit":true},{"date":"2021-12-31","value":45.83,"profit":true},{"date":"2022-12-31","value":86.45,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(1.91M)(8.33M)(35.83M)(67.59M)(78.19M)[{"date":"2019-12-31","value":-190800000,"profit":false},{"date":"2020-12-31","value":-833000000,"profit":false},{"date":"2021-12-31","value":-3583100000,"profit":false},{"date":"2022-12-31","value":-6759300000,"profit":false},{"date":"2023-12-31","value":-7819000000,"profit":false}]
Total Non-Operating Income/Expense-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Pre-Tax Income(2.05M)(8.28M)(35.53M)(63.31M)(66.86M)[{"date":"2019-12-31","value":-204700000,"profit":false},{"date":"2020-12-31","value":-828000000,"profit":false},{"date":"2021-12-31","value":-3553300000,"profit":false},{"date":"2022-12-31","value":-6330800000,"profit":false},{"date":"2023-12-31","value":-6686200000,"profit":false}]
Income Taxes139.00K(201.30K)(107.56K)(4.69M)(1.00)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-144.82,"profit":false},{"date":"2021-12-31","value":-77.38,"profit":false},{"date":"2022-12-31","value":-3374.82,"profit":false},{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Income From Continuous Operations(2.05M)(8.28M)(35.53M)(63.31M)(72.36M)[{"date":"2019-12-31","value":-204700000,"profit":false},{"date":"2020-12-31","value":-828000000,"profit":false},{"date":"2021-12-31","value":-3553300000,"profit":false},{"date":"2022-12-31","value":-6330800000,"profit":false},{"date":"2023-12-31","value":-7236000000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(2.05M)(8.28M)(35.53M)(58.62M)(66.86M)[{"date":"2019-12-31","value":-204700000,"profit":false},{"date":"2020-12-31","value":-828000000,"profit":false},{"date":"2021-12-31","value":-3553300000,"profit":false},{"date":"2022-12-31","value":-5861700000,"profit":false},{"date":"2023-12-31","value":-6686200000,"profit":false}]
EPS (Diluted)--(0.86)(1.14)(1.20)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-86,"profit":false},{"date":"2022-12-31","value":-114,"profit":false},{"date":"2023-12-31","value":-120,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

DSGN
Cash Ratio 34.19
Current Ratio 34.61

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

DSGN
ROA (LTM) -13.54%
ROE (LTM) -17.78%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

DSGN
Debt Ratio Lower is generally better. Negative is bad. 0.04
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.96

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

DSGN
Trailing PE NM
Forward PE NM
P/S (TTM) 22642.01
P/B 1.40
Price/FCF NM
EV/R 11004.35
EV/Ebitda NM

FAQs

What is Design Therapeutics Inc share price today?

Design Therapeutics Inc (DSGN) share price today is $6.335

Can Indians buy Design Therapeutics Inc shares?

Yes, Indians can buy shares of Design Therapeutics Inc (DSGN) on Vested. To buy Design Therapeutics Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in DSGN stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Design Therapeutics Inc be purchased?

Yes, you can purchase fractional shares of Design Therapeutics Inc (DSGN) via the Vested app. You can start investing in Design Therapeutics Inc (DSGN) with a minimum investment of $1.

How to invest in Design Therapeutics Inc shares from India?

You can invest in shares of Design Therapeutics Inc (DSGN) via Vested in three simple steps:

  • Click on Sign Up or Invest in DSGN stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Design Therapeutics Inc shares
What is Design Therapeutics Inc 52-week high and low stock price?

The 52-week high price of Design Therapeutics Inc (DSGN) is $7.77. The 52-week low price of Design Therapeutics Inc (DSGN) is $2.25.

What is Design Therapeutics Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Design Therapeutics Inc (DSGN) is

What is Design Therapeutics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Design Therapeutics Inc (DSGN) is 1.40

What is Design Therapeutics Inc dividend yield?

The dividend yield of Design Therapeutics Inc (DSGN) is 0.00%

What is the Market Cap of Design Therapeutics Inc?

The market capitalization of Design Therapeutics Inc (DSGN) is $353.88M

What is Design Therapeutics Inc’s stock symbol?

The stock symbol (or ticker) of Design Therapeutics Inc is DSGN

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top